on RedChip Companies, Inc. (Media Suite) (NASDAQ:JUNS)
Nexalin and Calidi Interviews to Feature on Bloomberg TV
This Saturday, Nexalin Technology and Calidi Biotherapeutics will be highlighted on the "RedChip Small Stocks, Big Money™" show, airing on Bloomberg TV. Nexalin's CEO, Mark White, discusses advancements in their non-invasive deep brain stimulation devices, supporting conditions like insomnia and PTSD, with a projected market worth $537 billion by 2030.
Calidi's CFO, Andrew Jackson, shares insights into the company's unique oncolytic virotherapy platforms. These are designed for a strategic cancer cell attack, supported by their clinical pipeline. Calidi aims to capture a market estimated between $13 billion and $15 billion. RedChip Companies sponsors this program, ensuring wide reach through Bloomberg TV's audience of 73 million U.S. homes.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all RedChip Companies, Inc. (Media Suite) news